Cargando…
Questionable Efficacy of Therapeutic Antibodies in the Treatment of Anthrax
Inhalational anthrax caused by Bacillus anthracis, a spore-forming Gram-positive bacterium, is a highly lethal infection. Antibodies targeting the protective antigen (PA) binding component of the toxins have recently been authorized as an adjunct to antibiotics, although no conclusive evidence demon...
Autores principales: | Tournier, Jean-Nicolas, Rougeaux, Clémence, Biot, Fabrice V., Goossens, Pierre L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584371/ https://www.ncbi.nlm.nih.gov/pubmed/31217301 http://dx.doi.org/10.1128/mSphere.00282-19 |
Ejemplares similares
-
In vivo dynamics of active edema and lethal factors during anthrax
por: Rougeaux, Clémence, et al.
Publicado: (2016) -
Corrigendum: In vivo dynamics of active edema and lethal factors during anthrax
por: Rougeaux, Clémence, et al.
Publicado: (2017) -
Anthrax Toxin Detection: From In Vivo Studies to Diagnostic Applications
por: Tournier, Jean-Nicolas, et al.
Publicado: (2020) -
Very Early Blood Diffusion of the Active Lethal and Edema Factors of Bacillus anthracis After Intranasal Infection
por: Rougeaux, Clémence, et al.
Publicado: (2020) -
Case Report of an Injectional Anthrax in France, 2012
por: Thouret, Jean-Marc, et al.
Publicado: (2020)